A Phase 2 Study of Encorafenib in Combination with Binimetinib in Patients with Metastatic BRAF -Mutated Thyroid Cancer in Japan
Thyroid® · 14.03.2024
DOI: 10.1089/thy.2023.0547 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Thyroid®, online erschienen am 14.03.2024. Verfasst von Makoto Tahara und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. Hauptthemen laut MEDLINE: Benzimidazoles, Carbamates, Sulfonamides, Thyroid Carcinoma, Anaplastic. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
- Department of Medical Oncology and Hematology, Cancer Center, Kobe University Hospital, Kobe, Hyogo, Japan.
- Department of Medical Oncology, Tohoku University Hospital, Sendai, Miyagi, Japan.
- Department of Medical Oncology, The Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, Japan.
- Department of Medical Oncology, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.
- Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Fukuoka, Japan.
Zitieren
APA
Tahara, M., Kiyota, N., Imai, H., Takahashi, S., Nishiyama, A., Tamura, S., Shimizu, Y., Kadowaki, S., Ito, K. I., Toyoshima, M., Hirashima, Y., Ueno, S., & Sugitani, I. (2024). A Phase 2 Study of Encorafenib in Combination with Binimetinib in Patients with Metastatic BRAF -Mutated Thyroid Cancer in Japan. Thyroid®. https://doi.org/10.1089/thy.2023.0547
Vancouver
Tahara M, Kiyota N, Imai H, Takahashi S, Nishiyama A, Tamura S, et al. A Phase 2 Study of Encorafenib in Combination with Binimetinib in Patients with Metastatic BRAF -Mutated Thyroid Cancer in Japan. Thyroid®. 2024. doi:10.1089/thy.2023.0547
BibTeX
@article{Tahara2024,
author = {Tahara, Makoto and Kiyota, Naomi and Imai, Hiroo and Takahashi, Shunji and Nishiyama, Akihiro and Tamura, Shingo and Shimizu, Yasushi and Kadowaki, Shigenori and Ito, Ken-Ichi and Toyoshima, Masahiro and Hirashima, Yoshinori and Ueno, Shinji and Sugitani, Iwao},
title = {A Phase 2 Study of Encorafenib in Combination with Binimetinib in Patients with Metastatic BRAF -Mutated Thyroid Cancer in Japan},
journal = {Thyroid®},
year = {2024},
doi = {10.1089/thy.2023.0547}
}
EUVIMED